Drug Approval | October 07, 2023
Lupin receives tentative approval from USFDA for Tolvaptan Tablets
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Minister was briefed on the nationwide dengue situation
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Subscribe To Our Newsletter & Stay Updated
